After infection, EBV maintains latency in most cells, and EBV latency is regulated by latent membrane protein (LMP) 2A, which mimics the B-cell receptor (BCR) and perturbs BCR signaling [7,8,9,10,11,12]. This evidence concerns the gene BCR and infection.